PAR 0.00% 21.0¢ paradigm biopharmaceuticals limited..

Ann: PARADIGM ACHIEVES FIRST REVENUE, page-8

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 4,368 Posts.
    lightbulb Created with Sketch. 6917
    Ahh I have waited for this one for a long time...first time revenue....love it.

    Indeed it will be modest, there aren't a lot that get RRV...of these there is a smaller subset that have the Chronic rendition of it.
    Within this there will be a further smaller group that will be bothered and motivated to go to the Doc or find a pathway to hear about iPPS (as it is limited, not all Docs know about it, actually the vast majority dont and wont, its strictly limited) AND then finally there are those patients that fall into the subset that are willing and able to pay out of pocket! (I'm hearing rumours of $5 K for the treatment which would include Doc's/Clinic's fees).


    BUT it is some revenue and it proves the model..this is what it is important. Word of mouth will slowly spread....PAR can use this as a practical example of the model at play for any Big Pharmas snooping around.

    Beautiful.


 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.